Free Trial

StockNews.com Begins Coverage on Veradigm (NASDAQ:MDRX)

Veradigm logo with Business Services background

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a research note released on Thursday morning. The firm issued a hold rating on the software maker's stock.

Separately, Stephens upped their price objective on Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a research note on Friday, January 31st.

Get Our Latest Report on Veradigm

Veradigm Price Performance

Shares of MDRX traded up $0.05 during trading hours on Thursday, reaching $4.15. The stock had a trading volume of 5,963 shares, compared to its average volume of 440,085. The firm has a 50-day simple moving average of $4.78 and a 200 day simple moving average of $7.79. Veradigm has a 12 month low of $3.80 and a 12 month high of $11.80.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines